Join us for this upcoming webinar, organized by Technobis, on polymer screening for amorphous solid dispersions (ASDs) using the Crystal16!
- Date: Thursday, 2nd of October 2025
- Time: 4.00 pm CEST
- Speaker: Thierry Bonnaud, Principal Scientist – Solid Form and Particle Engineering at Veranova
- Participation is free
About:
Amorphous solid dispersions (ASDs) are advanced pharmaceutical formulations in which a poorly water-soluble drug is dispersed within an amorphous polymer matrix.
In this non-crystalline form, the drug exhibits enhanced apparent solubility. While various polymers can be considered, the optimal polymer must effectively maintain supersaturation by inhibiting drug crystallization.
In this webinar, we demonstrate the application of the solvent shift method as a preliminary screening tool to reduce the number of polymers selected for further evaluation.
Piroxicam, a BCS Class II non steroidal anti-inflammatory drug (NSAID) with low aqueous solubility, was used as the model compound. The use of the Crystal16 system in screening polymers for piroxicam with the solvent shift method will be discussed in detail.